Literature DB >> 2914285

Gastric cancer heterogeneity.

X de Aretxabala1, Y Yonemura, K Sugiyama, N Hirose, T Kumaki, S Fushida, K Miwa, I Miyazaki.   

Abstract

This study was carried out on 222 samples from 37 gastric carcinomas to assess the incidence of multiple stem lines in primary tumors and metastasis as reflected by multiple DNA stem lines and their relationship to epidermal growth factor (EGF) receptor expression, histologic grade, tumor size, and degree of wall infiltration. Fifteen primary tumors (40.5%) were homogeneously diploid/peridiploid whereas 22 (59.5%) were aneuploid. In the lymph node metastasis, seven patients (29.2%) had an homogeneous diploid/peridiploid pattern in all metastatic lymph nodes. On the other hand, 17 (70.8%) had at least one aneuploid peak in the lymph node metastasis. DNA content heterogeneity was seen in 12 (33%) of primary tumors whereas 14 (66.6%) of 21 patients had multiple cell clones in the metastasis. Therefore, 12 patients had a metastatic clone which was not observed in the primary tumor. DNA content heterogeneity was seen even in tumors with submucosal invasion suggesting that this phenomenon is also present at earlier stages. No correlation between the histologic grade and the DNA distribution was observed. Furthermore, histologic heterogeneity was independent of DNA content heterogeneity. The EGF receptor expression was observed in six of the 23 patients in whom this analysis was done. The EGF receptor expression was constant in all samples which were studied and even samples with a different DNA content and histologic grade were stables for the EGF receptor expression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2914285     DOI: 10.1002/1097-0142(19890215)63:4<791::aid-cncr2820630431>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  DNA-ploidy and survival in gastric carcinomas: a flow-cytometric study.

Authors:  G Baretton; O Carstensen; M Schardey; U Löhrs
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Mucin-producing pancreatic tumors: a study of nuclear DNA content by flow cytometry.

Authors:  Y Murakami; T Yokoyama; T Kodama; Y Takesue; M Okita; A Nakamitsu; Y Imamura; T Santo; H Tsumura; K Miyamoto
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

3.  DNA ploidy and biologic aggressiveness of gastric adenocarcinoma in Chinese.

Authors:  K L Shen; C H Chu
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

4.  The succinate dehydrogenase inhibition test for evaluating biopsy specimens and resected tumors of advanced gastric cancer.

Authors:  H Kimura; Y Yonemura; S Ohyama; K Tsugawa; K Kinoshita; I Ninomiya; T Kosaka; K Miwa; I Miyazaki; M Tanaka
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

5.  FGFR2, HER2 and cMet in gastric adenocarcinoma: detection, prognostic significance and assessment of downstream pathway activation.

Authors:  Guy Betts; Helen Valentine; Sue Pritchard; Richard Swindell; Victoria Williams; Shethah Morgan; Ewen A Griffiths; Ian Welch; Catharine West; Christopher Womack
Journal:  Virchows Arch       Date:  2013-12-04       Impact factor: 4.064

6.  Correlation of DNA content between endoscopic biopsy and surgically resected specimens in gastric and colorectal cancer.

Authors:  S Moriwaki; O Kimura
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

7.  Near-diploid transitional cell carcinoma: a preliminary report.

Authors:  N H Chow; T S Tzai; S N Lin; W C Su; H L Cheng
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

8.  Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study.

Authors:  K H Lee; J S Lee; J H Lee; S W Kim; C Suh; W K Kim; S H Kim; Y I Min; B S Kim; K C Park; M S Lee; H S Sun
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

9.  Hypoxia-mediated CD24 expression is correlated with gastric cancer aggressiveness by promoting cell migration and invasion.

Authors:  Nobuaki Fujikuni; Hideki Yamamoto; Kazuaki Tanabe; Yutaka Naito; Naoya Sakamoto; Yuka Tanaka; Kazuyoshi Yanagihara; Naohide Oue; Wataru Yasui; Hideki Ohdan
Journal:  Cancer Sci       Date:  2014-10-18       Impact factor: 6.716

10.  Intra-Tumoral Heterogeneity of HER2, FGFR2, cMET and ATM in Gastric Cancer: Optimizing Personalized Healthcare through Innovative Pathological and Statistical Analysis.

Authors:  Peng Ye; Meizhuo Zhang; Shuqiong Fan; Tianwei Zhang; Haihua Fu; Xinying Su; Paul R Gavine; Qiang Liu; Xiaolu Yin
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.